Opportunity

SAM #SPE2DSFY28_Reagents

DLA Troop Support Europe & Africa market research for laboratory supplies

Buyer

DLA Troop Support

Posted

October 01, 2026

Respond By

October 30, 2026

Identifier

SPE2DSFY28_Reagents

NAICS

325413, 423490

DLA Troop Support Europe & Africa is seeking market information on laboratory supplies for military medical facilities and operational forces. - Government buyer: Defense Logistics Agency (DLA) Troop Support Europe & Africa, coordinating with the United States Army Medical Materiel Center-Europe (USAMMCE). USAMMCE is identified as the primary ordering activity and logistics hub. - OEMs named: Abbott (i-STAT) and Siemens (DCA 2000), cited as examples of Government-owned laboratory analyzer platforms. - Products requested: Clinical laboratory reagents, test cartridges, calibrators, controls, and related consumables for Government-owned laboratory analyzers and other capital equipment. - Compatibility requirement: Supplies must support the Government’s existing equipment. The notice does not provide specific part numbers or quantities. - Supported users and locations: DoD medical treatment facilities and operational forces in the EUCOM theater, with potential support for CENTCOM. - Procurement context: Market research for a follow-on laboratory-supplies requirement; no detailed product schedule or attachment information was provided.

Description

DLA – TS E&A, in conjunction with the United States Army Medical Materiel Center-Europe (USAMMCE), is conducting market research to support the recompete of its commercial laboratory supplies contract.

The resulting contract will provide clinical laboratory reagents, test cartridges, calibrators, controls, and associated consumables that operate in conjunction with specific Government-owned laboratory analyzers and capital equipment (e.g., Abbott i-STAT, Siemens DCA 2000, and other point-of-care or automated platforms).

The primary ordering activity and logistics hub is USAMMCE, servicing Department of Defense (DoD) medical treatment facilities and operational forces across the European Command (EUCOM) and possibly Central Command (CENTCOM) theaters. The follow-on ordering period is projected to commence on 15 January 2028.

View original listing